Easing Decision Making Stress When Younger Women Have Breast Cancer
July 31st 2015A diagnosis of breast cancer is difficult at any age but for younger women, treatment decisions can be especially difficult, with implications that include their future childbearing, sexual health, and body image.
Web Tools Expand Access to Psychosocial Care for Men With Prostate and Other Cancers
July 31st 2015Two web-based interventions that help men with prostate cancer deal with sexual dysfunction and other common side effects of treatment are demonstrating how tech tools can be successfully deployed to address the psychosocial needs of patients, their caregivers, and survivors.
Improving Cancer Care By "Capturing the Patient's Voice"
July 30th 2015For oncology clinicians and practices who want to meet new standards for more patient-centered cancer care, they need to do a better job of engaging patients more fully in their care planning and make patient-reported outcomes an integral part of cancer treatment research.
Many Young Cancer Patients Not Well Aware of Fertility Preservation Options
July 28th 2015Although it is important for clinicians and their patients who are receiving anticancer treatment to discuss patients' fertility preservation options, a new study has found that whether these conversations take place and, importantly, whether ensuing action is taken, depends on a number of factors.
Women in Appalachia Need Support to Optimize Their Adjuvant Breast Cancer Therapy
July 28th 2015A new study has uncovered notable disparities in uptake of adjuvant breast cancer therapies in the Appalachian region of the United States, suggesting targeted intervention strategies may help to improve outcomes for this population of women.
Expert Group Hopes to Mobilize Patients to Call for Cancer Drug Pricing Reforms
July 23rd 2015A group of 118 well-known cancer experts have come together to spotlight the escalating costs of cancer treatment with an aim to galvanize patients and grassroots advocates to make their voices heard.
Nivolumab Extends Survival in Kidney Cancer
July 22nd 2015A phase III trial evaluating the efficacy of nivolumab (Opdivo) for the treatment of advanced renal cell carcinoma has been stopped early after the immunotherapy agent demonstrated a survival advantage over the comparator drug, everolimus (Afinitor), in the CheckMate-025 trial.